Choksi Laboratories Limited Press Release Aug 21 2026

On conclusion of the inspection, the Company received 4 (Four) observations. We are addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe. The Company reaffirms its commitment to fully comply with USFDA regulations and to maintain the highest standards of quality and regulatory compliance at all times. Prakhar Dubey Company Secretary & Compliance